Bifidobacterium breve VPro 52 and Reduced Small-Intestinal Damage

• Bifidobacterium breve Bif195 Protects Against Small-intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers.

  • 2019-09
  • RCT · n = 75
  • Gastroenterology 157(3)
  • • Brynjulf Mortensen
    • C. Murphy
    • J. O’Grady
    • M. Lucey
    • G. Elsafi
    • L. Barry
    • V. Westphal
    • A. Wellejus
    • O. Lukjancenko
    • A. Eklund
    • H. Nielsen
    • Adam Baker
    • A. Damholt
    • J. V. H. van Hylckama Vlieg
    • F. Shanahan
    • M. Buckley

  • PubMed: 31095949
  • DOI: 10.1053/j.gastro.2019.05.008

  10 Insights on

  • Reduced Small-Intestinal Damage

  • High evidence

  The AUC for Lewis score was significantly lower in the Bif195 group (3040 ± 1340 arbitrary units) than the placebo group (4351 ± 3195) (P = .0376).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes